TR200201204T2 - Prevention of plaque rupture with ACAT inhibitors. - Google Patents

Prevention of plaque rupture with ACAT inhibitors.

Info

Publication number
TR200201204T2
TR200201204T2 TR2002/01204T TR200201204T TR200201204T2 TR 200201204 T2 TR200201204 T2 TR 200201204T2 TR 2002/01204 T TR2002/01204 T TR 2002/01204T TR 200201204 T TR200201204 T TR 200201204T TR 200201204 T2 TR200201204 T2 TR 200201204T2
Authority
TR
Turkey
Prior art keywords
prevention
plaque rupture
acat inhibitors
relates
rupture
Prior art date
Application number
TR2002/01204T
Other languages
Turkish (tr)
Inventor
Michael Andrew Bocan Thomas
Original Assignee
Warner Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Company filed Critical Warner Lambert Company
Publication of TR200201204T2 publication Critical patent/TR200201204T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Bu bulus, ateroskleroz lezyonlarinda monosit-makrofaz birikmesini ve MMP ifadesini önlemek için bir ACAT inhibitörü verilmesiyle ilgilidir. Dahasi bu bulus, aterosklerotik plaklarin destabilizasyonu ve/veya da kopmasini inhibe etme ve stabil olmayan anjin tedavisi yöntemleri ile de ilgilidir.This invention relates to the administration of an ACAT inhibitor to prevent monocyte-macrophase accumulation and MMP expression in atherosclerosis lesions. Moreover, this invention relates to methods of inhibiting destabilization and / or rupture of atherosclerotic plaques and treatment of unstable angina.

TR2002/01204T 1999-11-05 2000-10-17 Prevention of plaque rupture with ACAT inhibitors. TR200201204T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16381499P 1999-11-05 1999-11-05

Publications (1)

Publication Number Publication Date
TR200201204T2 true TR200201204T2 (en) 2002-08-21

Family

ID=22591694

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01204T TR200201204T2 (en) 1999-11-05 2000-10-17 Prevention of plaque rupture with ACAT inhibitors.

Country Status (19)

Country Link
EP (1) EP1229907A1 (en)
JP (1) JP2003513909A (en)
KR (1) KR20020050257A (en)
CN (1) CN1414848A (en)
AR (1) AR026354A1 (en)
AU (1) AU1210401A (en)
CA (1) CA2382676A1 (en)
CO (1) CO5270017A1 (en)
GT (1) GT200000193A (en)
HU (1) HUP0203160A3 (en)
IL (1) IL149145A0 (en)
PA (1) PA8506101A1 (en)
PE (1) PE20011027A1 (en)
PL (1) PL355148A1 (en)
SV (1) SV2001000207A (en)
TR (1) TR200201204T2 (en)
UY (1) UY26427A1 (en)
WO (1) WO2001034127A1 (en)
ZA (1) ZA200201755B (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060111898A (en) 2003-08-29 2006-10-30 교와 가부시키가이샤 Method of stabilizing lipid-rich plaque and method of preventing rupture thereof
US20080044404A1 (en) * 2004-04-15 2008-02-21 Anna Cederholm Annexin V for Preventing Atherothrombosis and Plaque Rupture
ES2775125T3 (en) 2010-11-03 2020-07-23 Dow Agrosciences Llc Pesticide compositions and related procedures
US8937083B2 (en) 2011-10-26 2015-01-20 DowAgroSciences, LLC Pesticidal compositions and processes related thereto
US9282739B2 (en) 2012-04-27 2016-03-15 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
JP6189937B2 (en) 2012-04-27 2017-08-30 ダウ アグロサイエンシィズ エルエルシー Agrochemical compositions and methods relating thereto
US9708288B2 (en) 2012-04-27 2017-07-18 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
JP2016536296A (en) 2013-10-17 2016-11-24 ダウ アグロサイエンシィズ エルエルシー Method for producing pest control compound
JP2016536295A (en) 2013-10-17 2016-11-24 ダウ アグロサイエンシィズ エルエルシー Method for producing pest control compound
CN105636446B (en) 2013-10-17 2018-07-13 美国陶氏益农公司 The method for preparing Pesticidal compound
KR20160072155A (en) 2013-10-17 2016-06-22 다우 아그로사이언시즈 엘엘씨 Processes for the preparation of pesticidal compounds
JP2016535010A (en) 2013-10-17 2016-11-10 ダウ アグロサイエンシィズ エルエルシー Method for producing pest control compound
US9102655B2 (en) 2013-10-17 2015-08-11 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
KR20160072154A (en) 2013-10-17 2016-06-22 다우 아그로사이언시즈 엘엘씨 Processes for the preparation of pesticidal compounds
EP3060052A4 (en) 2013-10-22 2017-04-05 Dow AgroSciences LLC Synergistic pesticidal compositions and related methods
AR098098A1 (en) 2013-10-22 2016-05-04 Dow Agrosciences Llc SYNERGIC PESTICIATED COMPOSITIONS AND RELATED METHODS
CN105828610B (en) 2013-10-22 2019-07-19 美国陶氏益农公司 Pesticidal combination and relative method
JP2016534086A (en) 2013-10-22 2016-11-04 ダウ アグロサイエンシィズ エルエルシー Synergistic pest control compositions and related methods
MX2016005316A (en) 2013-10-22 2017-03-01 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods.
CA2926438A1 (en) 2013-10-22 2015-04-30 Dow Agrosciences Llc Pesticidal compositions and related methods
MX2016005323A (en) 2013-10-22 2016-08-12 Dow Agrosciences Llc Pesticidal compositions and related methods.
JP2016535025A (en) 2013-10-22 2016-11-10 ダウ アグロサイエンシィズ エルエルシー Synergistic pest control compositions and related methods
WO2015061155A1 (en) 2013-10-22 2015-04-30 Dow Agrosciences Llc Pesticidal compositions and related methods
KR20160074621A (en) 2013-10-22 2016-06-28 다우 아그로사이언시즈 엘엘씨 Synergistic pesticidal compositions and related methods
CN105848480A (en) 2013-10-22 2016-08-10 美国陶氏益农公司 Synergistic pesticidal compositions and related methods
TW201519780A (en) 2013-10-22 2015-06-01 Dow Agrosciences Llc Pesticidal compositions and related methods
MX2016005325A (en) 2013-10-22 2016-08-08 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods.
EP3060055A4 (en) 2013-10-22 2017-03-29 Dow AgroSciences LLC Synergistic pesticidal compositions and related methods
US9808008B2 (en) 2013-10-22 2017-11-07 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods
CA2927202A1 (en) 2013-10-22 2015-04-30 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods
AU2014340430B2 (en) 2013-10-22 2017-05-25 Dow Agrosciences Llc Pesticidal compositions and related methods
CN106470976A (en) 2014-07-31 2017-03-01 美国陶氏益农公司 The method of preparation 3 (3 chlorine 1H pyrazoles 1 base) pyridine
EP3186229A4 (en) 2014-07-31 2018-01-10 Dow AgroSciences LLC Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine
EP3174856A4 (en) 2014-07-31 2018-01-10 Dow AgroSciences LLC Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine
US9024031B1 (en) 2014-08-19 2015-05-05 Dow Agrosciences Llc Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
BR112017004613A2 (en) 2014-09-12 2017-12-05 Dow Agrosciences Llc Process for the preparation of 3- (3-chloro-1h-pyrazol-1-yl) pyridine
CA2961166C (en) * 2014-10-21 2021-04-13 Council Of Scientific And Industrial Research Alkylidene phosphonate esters as p-glycoprotein inducers
US20190275012A9 (en) * 2016-07-29 2019-09-12 Lupin Limited Substituted thiazolo-pyridine compounds as malt1 inhibitors
WO2018093966A1 (en) * 2016-11-16 2018-05-24 Purdue Research Foundation Compositions and methods for regulating body weight and metabolic syndromes
WO2018125817A1 (en) 2016-12-29 2018-07-05 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
EP3562807B1 (en) 2016-12-29 2022-08-03 Corteva Agriscience LLC Processes for the preparation of pesticidal compounds
CU20200038A7 (en) 2017-10-27 2021-03-11 Bayer Ag COMPOUNDS DERIVED FROM PYRAZOLO-PIRROLO-PYRIMIDINE-DIONA AS INHIBITORS OF P2X3
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2067254T3 (en) * 1990-10-30 1995-03-16 Warner Lambert Co OXISULFONILCARBAMATOS.
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
IT1270976B (en) * 1993-08-06 1997-05-26 Pierrel Spa INHIBITIVE COMPOUNDS OF ACYL ENZYME-A-CHOLESTEROL-O-ACYL TRANSFERASE TO THERAPEUTIC ACTIVITIES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
EE9800037A (en) * 1995-08-04 1998-08-17 Warner-Lambert Company Use of sulphamic acid derivatives, acylsulphonamides or sulphonylcarbamates in the manufacture of a medicament for reducing lipoprotein levels
WO1997016184A1 (en) * 1995-11-02 1997-05-09 Warner-Lambert Company Method and pharmaceutical composition for regulating lipid concentration
OA11584A (en) * 1998-07-21 2004-07-20 Warner Lambert Co Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions.

Also Published As

Publication number Publication date
WO2001034127A1 (en) 2001-05-17
CN1414848A (en) 2003-04-30
PE20011027A1 (en) 2001-10-16
CO5270017A1 (en) 2003-04-30
PL355148A1 (en) 2004-04-05
GT200000193A (en) 2002-04-27
AU1210401A (en) 2001-06-06
CA2382676A1 (en) 2001-05-17
PA8506101A1 (en) 2002-10-28
JP2003513909A (en) 2003-04-15
UY26427A1 (en) 2000-12-29
ZA200201755B (en) 2003-08-27
SV2001000207A (en) 2001-10-16
HUP0203160A3 (en) 2006-02-28
AR026354A1 (en) 2003-02-05
IL149145A0 (en) 2002-11-10
EP1229907A1 (en) 2002-08-14
KR20020050257A (en) 2002-06-26
HUP0203160A2 (en) 2003-01-28

Similar Documents

Publication Publication Date Title
TR200201204T2 (en) Prevention of plaque rupture with ACAT inhibitors.
BR9908280A (en) Phospholipase enzyme inhibitors
BG105369A (en) Arylpiperazines and their use as metalloproteinase inhibiting agent (mmp
DK0981607T3 (en) Modified arginine deiminase
CY1110385T1 (en) Use of IL-18 inhibitors for the treatment and / or prevention of atherosclerosis
NO20015462D0 (en) Use of phthalazine derivatives
TR200001041T2 (en) Synergistic analgesic combination of opioid analgesic and cycloxygenase-2 inhibitor.
GEP20032920B (en) Inhibitors of Phospholipase Enzymes
ATE287402T1 (en) NANOMOLAR, NON-PEPTIDIC INHIBITORS OF CATHEPSIN D
BR9909242A (en) A2 phospholipase inhibitors
ID30139A (en) COMPLEX OF RAS-FARNESILTRANSFERASE AND SULFOBUTILETER-7- INHIBITORS OR CYCLODEXTRINS OR 2-HYDROXYXYOPROPYL--SICLODODSTRINTS AND ITS METHODS
DK1268847T3 (en) Ubiquitin ligaseassay
TR200502508T2 (en) Use of IL-18 Inhibitors.
IS5553A (en) Quinolone as Serine Protein Chaperone Inhibitors
TR199800773T2 (en) Thrombin inhibitors.
PT817622E (en) MEDICATIONS CONTAINING ACE INHIBITORS TRANSDERMICALLY APPLICABLE
DE60001735D1 (en) 1-AMINOTRIAZOLO 4,3-A CHINAZOLIN-5-ONE AND / OR -THIONE INHIBITORS OF PHOSPHODIESTERASES IV
HUP0401854A2 (en) Combinations comprising cox-2 inhibitors and aspirin
ATE264328T1 (en) SUBSTITUTED 3-CYANO-(1.7), (1.5) AND (1.8)NAPHTHHYRIDINE INHIBITORS OF TYROSINE KINASES
BR9813778A (en) Use of at least one fucan.
DE69917230D1 (en) COMBINATION PRODUCT CONTAINING SELECTIVE NMDA NR2B ANTAGONISTS AND COX-2 INHIBITORS
TR199901703T2 (en) Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents.
WO2002059084A3 (en) Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases, and uses thereof
NO20034951D0 (en) An assay to detect inhibitors of the enzyme myeloperoxidase
EE200100061A (en) Prevention of recurrence of migraine